According to Thomas Seyfried, how can metabolic therapies treat cancer? 

Seyfried's groundbreaking research challenges the conventional understanding of cancer, proposing it as primarily a metabolic disease rather than solely genetic. His work delves into the intricate mechanisms of dysfunctional mitochondrial metabolism, emphasizing the role of metabolic therapies in reshaping the cancerous environment.

Through methods such as caloric restriction, fasting, and ketogenic diets, Seyfried aims to induce a global metabolic shift, exploiting the disparities between normal and cancer cells.

By depriving cancer cells of their preferred energy source, glucose, and redirecting their metabolism towards ketone bodies, these therapies induce metabolic stress, ultimately leading to tumor regression or management.

Central to Seyfried's approach is the ketogenic diet, characterized by its high-fat, low-carbohydrate composition, which starves cancer cells of glucose while promoting the metabolic health of normal cells. By targeting the metabolic vulnerabilities of cancer cells, Seyfried's research offers a promising alternative to traditional chemotherapies, focusing on correcting the underlying metabolic defects that drive tumor growth.

In essence, Seyfried advocates for leveraging non-toxic metabolic therapies to create a hostile metabolic environment for cancer cells, while simultaneously enhancing the metabolic efficiency of healthy cells, presenting a novel strategy for cancer treatment rooted in the metabolic theory.